TRACEE HARRIS: Open Payments
NPI 1376114959 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,268 in 164 payments from 20 companies in 2025. Trend: 2023 $2,870 · 2024 $2,725 · 2025 $3,268
Food & beverage: $3,239Education: $29
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $557 |
| Otsuka America Pharmaceutical, Inc. | 23 | $411 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $366 |
| E.R. Squibb & Sons, L.L.C. | 7 | $323 |
| Lundbeck LLC | 14 | $322 |
| Axsome Therapeutics, Inc. | 16 | $301 |
| Corium, LLC | 10 | $225 |
| LivaNova USA, Inc. | 4 | $114 |
| Teva Pharmaceuticals USA, Inc. | 4 | $103 |
| Almatica Pharma LLC | 5 | $87 |
Products named: REXULTI, VRAYLAR, CAPLYTA, COBENFY, Auvelity, Azstarys, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, UZEDY.
Industry payments across TX — which companies pay providers there.
